SELLAS Life Sciences (SLS) Retained Earnings (2019 - 2024)
SELLAS Life Sciences (SLS) has disclosed Retained Earnings for 9 consecutive years, with -$241.4 million as the latest value for Q3 2024.
- Quarterly Retained Earnings fell 15.45% to -$241.4 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was -$241.4 million through Sep 2024, down 15.45% year-over-year, with the annual reading at -$217.2 million for FY2023, 20.76% down from the prior year.
- Retained Earnings for Q3 2024 was -$241.4 million at SELLAS Life Sciences, down from -$234.3 million in the prior quarter.
- The five-year high for Retained Earnings was -$105.3 million in Q1 2020, with the low at -$241.4 million in Q3 2024.
- Average Retained Earnings over 5 years is -$165.9 million, with a median of -$163.8 million recorded in 2022.
- The sharpest move saw Retained Earnings decreased 13.87% in 2021, then tumbled 31.09% in 2022.
- Over 5 years, Retained Earnings stood at -$117.9 million in 2020, then decreased by 17.56% to -$138.6 million in 2021, then decreased by 29.8% to -$179.9 million in 2022, then decreased by 20.76% to -$217.2 million in 2023, then dropped by 11.12% to -$241.4 million in 2024.
- According to Business Quant data, Retained Earnings over the past three periods came in at -$241.4 million, -$234.3 million, and -$226.8 million for Q3 2024, Q2 2024, and Q1 2024 respectively.